Cargando…

Interaction of Proteins Involved in Neuronal Proteinopathies

Proteinopathy is characterized by the accumulation of aggregates of a specific protein in a target organ, tissue, or cell. The aggregation of the same protein can cause different pathologies as single protein can adopt various amyloidogenic, disease-specific conformations. The conformation governs t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kulichikhin, Konstantin Y., Malikova, Oksana A., Zobnina, Anastasia E., Zalutskaya, Natalia M., Rubel, Aleksandr A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608209/ https://www.ncbi.nlm.nih.gov/pubmed/37895336 http://dx.doi.org/10.3390/life13101954

Ejemplares similares

Development of molecular tools for diagnosis of Alzheimer’s disease that are based on detection of amyloidogenic proteins
por: Kulichikhin, Konstantin Y., et al.
Publicado: (2021)

Functional Mammalian Amyloids and Amyloid-Like Proteins
por: Rubel, Maria S., et al.
Publicado: (2020)

Parkinson’s disease: proteinopathy or lipidopathy?
por: Fanning, Saranna, et al.
Publicado: (2020)

Karyopherin abnormalities in neurodegenerative proteinopathies
por: Pasha, Terouz, et al.
Publicado: (2021)

Altered Mitochondrial Protein Homeostasis and Proteinopathies
por: Jishi, Aya, et al.
Publicado: (2022)

Protein Misfolding and Aggregation in Proteinopathies: Causes, Mechanism and Cellular Response
por: Ajmal, Mohammad Rehan
Publicado: (2023)

Proteinopathy-induced neuronal senescence: a hypothesis for brain failure in Alzheimer's and other neurodegenerative diseases
por: Golde, Todd E, et al.
Publicado: (2009)

Molecular Neuropathology of TDP-43 Proteinopathies
por: Neumann, Manuela
Publicado: (2009)

Proteinopathies and OXPHOS dysfunction in neurodegenerative diseases
por: Kawamata, Hibiki, et al.
Publicado: (2017)

Drosophila Answers to TDP-43 Proteinopathies
por: Romano, Maurizio, et al.
Publicado: (2012)

TDP-43 Proteinopathy Specific Biomarker Development
por: Cordts, Isabell, et al.
Publicado: (2023)

Mechanisms of aging-related proteinopathies in Caenorhabditis elegans
por: Kim, Dong-Kyu, et al.
Publicado: (2016)

Promiscuous Roles of Autophagy and Proteasome in Neurodegenerative Proteinopathies
por: Limanaqi, Fiona, et al.
Publicado: (2020)

The basis of clinicopathological heterogeneity in TDP-43 proteinopathy
por: Kawakami, Ito, et al.
Publicado: (2019)

Neurodegenerative diseases as proteinopathies-driven immune disorders
por: Ciccocioppo, Fausta, et al.
Publicado: (2019)

Neurodegenerative Proteinopathies in the Proteoform Spectrum—Tools and Challenges
por: Noor, Aneeqa, et al.
Publicado: (2021)

Linking Oxidative Stress and Proteinopathy in Alzheimer’s Disease
por: Sharma, Chanchal, et al.
Publicado: (2021)

Mechanisms of TDP-43 Proteinopathy Onset and Propagation
por: Chen, Han-Jou, et al.
Publicado: (2021)

Organotypic brain slice cultures to model neurodegenerative proteinopathies
por: Croft, C. L., et al.
Publicado: (2019)

Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis
por: Smethurst, Phillip, et al.
Publicado: (2020)

Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy
por: Korb, Manisha, et al.
Publicado: (2022)

Are Proteinopathy and Oxidative Stress Two Sides of the Same Coin?
por: Mehta, Nihar J., et al.
Publicado: (2019)

Mitochondrion-Dependent Cell Death in TDP-43 Proteinopathies
por: Lucini, Chantal B., et al.
Publicado: (2021)

Neurodegenerative proteinopathies associated with neuroinfections
por: Danics, Krisztina, et al.
Publicado: (2021)

Immunotherapy Targeting Neurodegenerative Proteinopathies: α-Synucleinopathies and Tauopathies
por: Shin, Junghwan, et al.
Publicado: (2020)

TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets
por: Scotter, Emma L., et al.
Publicado: (2015)

Molecular mechanisms of proteinopathies across neurodegenerative disease: a review
por: Marsh, Alexander P.
Publicado: (2019)

The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
por: Ubeda-Bañon, Isabel, et al.
Publicado: (2020)

Untangling the origin and function of granulovacuolar degeneration bodies in neurodegenerative proteinopathies
por: Wiersma, Vera I., et al.
Publicado: (2020)

Post-Ischemic Neurodegeneration of the Hippocampus Resembling Alzheimer’s Disease Proteinopathy
por: Pluta, Ryszard, et al.
Publicado: (2021)

TDP-43 Proteinopathy and Tauopathy: Do They Have Pathomechanistic Links?
por: Riku, Yuichi, et al.
Publicado: (2022)

Monoclonal full-length antibody against TAR DNA binding protein 43 reduces related proteinopathy in neurons
por: Pozzi, Silvia, et al.
Publicado: (2020)

Neurodegenerative Proteinopathies Induced by Environmental Pollutants: Heat Shock Proteins and Proteasome as Promising Therapeutic Tools
por: Moyano, Paula, et al.
Publicado: (2023)

Chronic traumatic encephalopathy and other neurodegenerative proteinopathies
por: Tartaglia, Maria Carmela, et al.
Publicado: (2014)

Dimebon Slows Progression of Proteinopathy in γ-Synuclein Transgenic Mice
por: Bachurin, Sergey O., et al.
Publicado: (2011)

Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder
por: De Marchi, Fabiola, et al.
Publicado: (2023)

Molecular Pathways Involved in Frontotemporal Lobar Degeneration with TDP-43 Proteinopathy: What Can We Learn from Proteomics?
por: Mol, Merel O., et al.
Publicado: (2021)

Expanding the TDP-43 Proteinopathy Pathway From Neurons to Muscle: Physiological and Pathophysiological Functions
por: Versluys, Lauren, et al.
Publicado: (2022)

Mechanisms and models of TDP-43 proteinopathies
por: Petrucelli, Leonard
Publicado: (2012)

Unravelling proteinopathies: an interview with David Rubinsztein
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hr9c5m8phmh6bh0c6cho6b3g0f